Annexon, Inc. (ANNX) vs Aura Biosciences, Inc. (AURA)

A side-by-side comparison of Annexon, Inc. and Aura Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Annexon, Inc. logo
ANNX
Annexon, Inc.
$671M
$4.10HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
Aura Biosciences, Inc. logo
AURA
Aura Biosciences, Inc.
$633M
$6.12HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT

Total return — ANNX vs AURA

growth of $100 · dividends reinvested · last 5y
ANNX -74.2% (-23.8%/yr)AURA -58.0% (-15.9%/yr)AURA compounded faster over this window
050100150Start $10020222023202420252026$26$42
ANNX AURA

ANNX vs AURA: by the numbers

  • •ANNX is the larger company ($671M vs $633M market cap).

Metrics side by side

Valuation

MetricANNXAURA
P/B ratio3.612.01

Profitability

MetricANNXAURA
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-108.93%-41.56%
ROIC-101.43%-42.02%

Growth (annualized)

MetricANNXAURA
Total return CAGR (5Y)-26.29%N/A

Go deeper

Full ANNX analysisFull AURA analysisInteractive comparison tool

Dig into the metrics

Annexon ROEAura Biosciences ROEAnnexon operating marginAura Biosciences operating marginAnnexon revenue growthAura Biosciences revenue growthAnnexon free cash flowAura Biosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.